EROX Financials 07/15/2014 18:50:32 Human Pheromo
Post# of 3
Human Pheromone Sciences, Inc.
Period Ending Dec 31, 2010
Total Revenue 806
Cost of Revenue 128
Gross Profit 678
Operating Expenses
Research and Development 23
Sales, General and Admin. 750
Non-Recurring Items -
Other -
Operating Income (95)
Income From Continuing Operations
Add'l Income/Expense Items -
Earnings Before Interest and Tax (95)
Interest Expense -
Earnings Before Tax (95)
Income Tax 2
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations (97)
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income (97)
Preferred Stock and Other Adjustments -
Net Income Applicable to Common Shareholders (97)